BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26087193)

  • 1. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
    de Sousa GR; Ribeiro TC; Faria AM; Mariani BM; Lerario AM; Zerbini MC; Soares IC; Wakamatsu A; Alves VA; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Oncotarget; 2015 Sep; 6(26):22724-33. PubMed ID: 26087193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.
    Caramuta S; Lee L; Ozata DM; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
    Endocr Relat Cancer; 2013 Aug; 20(4):551-64. PubMed ID: 23671264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.
    Faria AM; Sbiera S; Ribeiro TC; Soares IC; Mariani BM; Freire DS; de Sousa GR; Lerario AM; Ronchi CL; Deutschbein T; Wakamatsu A; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Fassnacht M; Almeida MQ
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):481-8. PubMed ID: 25200669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
    Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
    Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
    Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
    Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
    Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nestin as a marker in the classification of adrenocortical tumors.
    Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
    Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma: review and update.
    Erickson LA; Rivera M; Zhang J
    Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Sequencing Reveals Spatially Distributed Distinct Hot Spot Mutations in DICER1-Related Multinodular Goiter.
    de Kock L; Bah I; Revil T; Bérubé P; Wu MK; Sabbaghian N; Priest JR; Ragoussis J; Foulkes WD
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3637-3645. PubMed ID: 27459524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
    Eide HA; Halvorsen AR; Bjaanæs MM; Piri H; Holm R; Solberg S; Jørgensen L; Brustugun OT; Kiserud CE; Helland Å
    BMC Cancer; 2016 Feb; 16():71. PubMed ID: 26858029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in adrenocortical neoplasia.
    Assie G; Giordano TJ; Bertherat J
    Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
    Pereira SS; Máximo V; Coelho R; Batista R; Soares P; Guerreiro SG; Sobrinho-Simões M; Monteiro MP; Pignatelli D
    J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.
    de Sousa GR; Soares IC; Faria AM; Domingues VB; Wakamatsu A; Lerario AM; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Horm Metab Res; 2015 Aug; 47(9):656-61. PubMed ID: 25985323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.